NFL is a well-known serum/plasma/CSF biomarker of axonal damage in multiple forms of neurodegeneration (including multiple sclerosis, atypical parkinsonisms, frontotemporal dementia, amyotrophic lateral sclerosis, and prion diseases) [19–22]. This evidence concerns the gene NEFL and multiple sclerosis.